Please assess the completion status of the following clinical trial:

Trial Title: The CHOICE Registry

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Age ≥ 18~2. Diagnosis of metastatic CRC~3. Having completed first and second lines of treatment for metastatic CRC~4. Intending (at time of enrollment) to initiate a third (or subsequent) line of treatment~5. Ability to understand and read English or Spanish~6. Willing and able to sign an Informed Consent Form (ICF), or have a Legally Authorized Representative willing and able to consent on the patient's behalf~Exclusion Criteria:~1. Patient is unwilling or unable to participate in the Registry at the time of enrollment~2. The patient is currently participating in an investigational clinical trial~3. Patients not having mental capacity and or ability to participate in the Registry

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).